Fir Tree Capital Management’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Fir Tree Capital Management’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-125,409	Closed	-$82K	–	794
2021 Q4	$82K	Sell	125,409 -24,591	-16%	-$17.1K	﹤0.01%	619
2021 Q3	$99K	Hold	150,000	–	–	﹤0.01%	477
2021 Q2	$129K	Hold	150,000	–	–	﹤0.01%	465
2021 Q1	$92K	Buy	+150,000	New	+$106K	﹤0.01%	397

Other funds holding BIOTW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

KCM

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Fir Tree Capital Management's BIOTW Position: Q1 2022 in Review

Fir Tree Capital Management sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2022, closing a stake of 125,409 shares — an estimated $82K sold.

Fir Tree Capital Management first reported a position in BIOTW in Q1 2021 and held it in 4 quarters. The position peaked at $129K in Q2 2021. 52 funds tracked by Wall St. Rank hold BIOTW as of Q1 2022.

Fir Tree Capital Management reported no remaining Biotech Acquisition Company Warrant position as of Q1 2022 after selling out during the quarter.
Fir Tree Capital Management sold 125,409 Biotech Acquisition Company Warrant shares in Q1 2022, an estimated $82K.
Fir Tree Capital Management first reported a position in Biotech Acquisition Company Warrant in Q1 2021 and held it in 4 quarters.
Fir Tree Capital Management's Biotech Acquisition Company Warrant position peaked at $129K in Q2 2021.
52 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2022.

Based on Fir Tree Capital Management's 13F filing for Q1 2022, filed 16 May 2022.